120225-90-3 Usage
Uses
Used in Pharmaceutical Industry:
Cyclopentanecarboxylic acid, 1-amino-, 1,1-dimethylethyl ester (9CI) is used as an intermediate or building block for the synthesis of various organic compounds, contributing to the development of new pharmaceutical products.
Used in Agriculture Industry:
In the agricultural sector, Cyclopentanecarboxylic acid, 1-amino-, 1,1-dimethylethyl ester (9CI) serves as a precursor for the synthesis of bioactive compounds, potentially enhancing crop protection and productivity.
Used in Anti-Cancer Research:
Cyclopentanecarboxylic acid, 1-amino-, 1,1-dimethylethyl ester (9CI) is studied for its potential role as an anti-cancer agent, with ongoing research aimed at understanding its mechanism of action and therapeutic potential in treating various types of cancer.
Used in Central Nervous System Research:
Cyclopentanecarboxylic acid, 1-amino-, 1,1-dimethylethyl ester (9CI) is also being investigated for its ability to act on the central nervous system, with potential applications in the development of treatments for neurological disorders or conditions. Further research is necessary to explore its full potential in this area.
Check Digit Verification of cas no
The CAS Registry Mumber 120225-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,2,2 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 120225-90:
(8*1)+(7*2)+(6*0)+(5*2)+(4*2)+(3*5)+(2*9)+(1*0)=73
73 % 10 = 3
So 120225-90-3 is a valid CAS Registry Number.
120225-90-3Relevant academic research and scientific papers
ENZYME AND RECEPTOR MODULATION
-
Page/Page column 15, (2010/12/29)
Covalent conjugates of an α,α-disubstituted glycine ester and a modulator of the activity of a target intracellular enzyme or receptor, wherein the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid and the α,α-disubstituted glycine ester is conjugated to the modulator at a position remote from the binding interface between the inhibitor and the target enzyme or receptor pass into cells and the active acid hydrolysis product accumulates within the cells.
INHIBITORS OF P38 MAP KINASE
-
Page/Page column 40, (2009/10/21)
Compounds of formula (I) are p38 MAP kinase inhibitors useful for the treatment of autoimmune and inflammatory diseases: wherein: G is -N= or -CH=; D is an optionally substituted divalent mono- or bi-cyclic aryl or heteroaryl radical having 5 - 13 ring members; R6 is hydrogen or optionally substituted CrC3 alkyl; P represents hydrogen and U represents a radical of formula (IA); or U represents hydrogen and P represents a radical of formula (IA); wherein A represents an optionally substituted divalent mono- or bicyclic carbocyclic or heterocyclic radical having 5 - 13 ring members; z is O or 1; -X1-L1-Y- is a linker radical or bond; R1 is a carboxylic acid group (-COOH), or an ester group which is hydrolysable by one or more intracellular esterase enzymes to a carboxylic acid group; and R2 and R3 are as defined in the claims.
